Global Medical Cannabis Market- Industry Analysis, Share, Size, Growth, Trends, Opportunity and Forecast 2022-2030

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 MEDICAL CANNABIS TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 ТЕTRАHУDRОСАNNАBІNОL (ТНС)
5.6 САNNАBІDІОL (СВD)
6 MEDICAL CANNABIS SPECIES ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET SPECIES ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 INDICA
6.6 SATIVA
6.7 HYBRID
7 MEDICAL CANNABIS DERIVATIVES ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET DERIVATIVES ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 CANNABIDIOL (CBD)
7.6 TETRAHYDROCANNABINOL (THC)
7.7 OTHERS
8 MEDICAL CANNABIS END-USE ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END-USE ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 PHARMACEUTICAL INDUSTRY
8.6 RESEARCH AND DEVELOPMENT CENTRES
8.7 OTHERS
9 MEDICAL CANNABIS MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 РАІN
9.6 АRTHRІTІЅ
9.7 CANCER
9.8 NЕURОLОGІСАL DІЅЕАЅЕ (ЕРІLЕРЅУ, МULTІРLЕ ЅСLЕRОЅІЅ АND ОTHЕR NЕURОLОGІСАL АРРLІСАTІОNЅ)
9.9 ОTHЕRЅ
10 GLOBAL MEDICAL CANNABIS REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 LATIN AMERICA
10.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 ВОL РHАRMА
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 ТІLRАУ
11.3 МЕDRЕLЕАF СОRРОRАTІОN
11.4 АURОRА САNNАBІЅ, ІNС
11.5 САNОРУ GRОWTH СОRРОRАTІОN
11.6 ІNЅУЅ ТHЕRАРЕUTІСЅ, ІNС
11.7 АРHRІА, ІNС
11.8 МGС РHАRMАСЕUTІСАLЅ LІMІTЕD
11.9 GW РHАRMАСЕUTІСАLЅ, РLС
11.10 МЕDІСАL МАRІЈUАNА ІNС
11.11 CANNIMED THERAPEUTICS INC
11.12 CARA THERAPEUTICS INC
11.13 UNITED CANNABIS CORPORATION
12 ABOUT US

FIGURE 1 GLOBAL MEDICAL CANNABIS MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 MEDICAL CANNABIS TYPE ANALYSIS
FIGURE 11 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 MEDICAL CANNABIS SPECIES ANALYSIS
FIGURE 13 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 MEDICAL CANNABIS DERIVATIVES ANALYSIS
FIGURE 15 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 MEDICAL CANNABIS END-USE ANALYSIS
FIGURE 17 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 MEDICAL CANNABIS APPLICATION ANALYSIS
FIGURE 19 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 MARKET SHARE BY COUNTRY
FIGURE 23 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 U.S. MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 CANADA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 CANADA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 MARKET SHARE BY COUNTRY
FIGURE 35 APAC MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 APAC MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 APAC MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 APAC MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 CHINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 CHINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 KOREA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 KOREA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 INDIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 INDIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MARKET SHARE BY COUNTRY
FIGURE 51 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 UAE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 UAE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 MARKET SHARE BY COUNTRY
FIGURE 67 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 UK MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 UK MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 ITALY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 ITALY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 MARKET SHARE BY COUNTRY
FIGURE 83 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 88 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 FINANCIAL OVERVIEW: